Pain (dichotomous) Pain improved (definitions varied)c · people with radicular low back pain (not due to spinal stenosis)
Systemic corticosteroids showed no clear difference in pain (dichotomous) Pain improved (definitions varied)c compared with placebo (moderate certainty).
1 finding from 1 review
Function (continuous) SMD (scales varied) · people with radicular low back pain (not due to spinal stenosis)
1 finding from 1 review
Function (dichotomous) Function improved (definitions varied)f · people with radicular low back pain (not due to spinal stenosis)
Systemic corticosteroids probably leads to higher function (dichotomous) Function improved (definitions varied)f compared with placebo (moderate certainty).
1 finding from 1 review
Surgery Number of participants who underwent surgery · people with radicular low back pain (not due to spinal stenosis)
Systemic corticosteroids showed no clear difference in participants who underwent surgery Underwent surgery compared with placebo (moderate certainty).
1 finding from 1 review
Mortality or serious adverse events requiring hospital admission · people with radicular low back pain (not due to spinal stenosis)
It is very uncertain whether systemic corticosteroids changes participants who experienced a serious adverse event Adverse event… compared with placebo (very low certainty).
1 finding from 1 review
Participants with hyperglycemia "Transient hyperglycemia" or blood sugar increase ≥ 50 mg/dL · people with radicular low back pain (not due to spinal stenosis)
Systemic corticosteroids showed no clear difference in participants with hyperglycemia "Transient hyperglycemia" or blood… compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · people with non‐radicular low back pain
1 finding from 1 review
Pain (dichotomous) No pain in last 24 hours · people with non‐radicular low back pain
Systemic corticosteroids showed no clear difference in pain (dichotomous) No pain in last 24 hours compared with placebo (low certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Quality of life · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Retreatment · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ejaculatory disorders · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Quality of lifea · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
It is very uncertain whether PAE changes major adverse events compared with TURP (very low certainty).
1 finding from 1 review
Retreatmenta · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
PAE probably leads to higher retreatmenta compared with TURP (moderate certainty).
1 finding from 1 review
Erectile functiona · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
1 finding from 1 review
Ejaculatory disordersh · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
PAE may leads to lower ejaculatory disordersh compared with TURP (low certainty).
1 finding from 1 review
RR 0.51 [0.35, 0.73]
260 participants
Low